Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: EBOS Group Limited

Market Cap 3.66B 2.58B 2.23B 2.06B 1.93B 3.61B 246B 24.29B 9.47B 120B 9.7B 9.49B 414B P/E Ratio 2026 *
14.8x
P/E Ratio 2027 * 14.3x
Enterprise Value 4.67B 3.29B 2.85B 2.62B 2.45B 4.6B 313B 30.96B 12.07B 152B 12.36B 12.1B 528B EV / Sales 2026 *
0.34x
EV / Sales 2027 * 0.33x
Free-Float
90.77%
Yield 2026 *
5.57%
Yield 2027 * 5.45%
1 year 23.75
Extreme 23.75
23.75
3 years 20.02
Extreme 20.02
23.75
5 years 20.02
Extreme 20.02
28.25
10 years 20.02
Extreme 20.02
28.25
Manager TitleAgeSince
Chief Executive Officer 51 2025-06-30
Director of Finance/CFO - 2024-09-29
Chief Tech/Sci/R&D Officer - 2023-07-31
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 2019-06-30
Director/Board Member 59 2021-06-30
Change 5-day change 1-year change 3-year change Capi.($)
+15.85%-.--% - - 2.58B
-0.40%+1.08%+7.67%+100.40% 91.79B
+1.22%+8.82%+38.68%+157.39% 52.43B
+6.06%-4.11%-13.58%+227.49% 21.42B
+0.62%+0.49%-10.95%-26.63% 8.13B
-0.07%+2.43%-34.66%-30.16% 7.54B
-0.41%-0.88%-8.19%-35.87% 6.77B
-1.83%-0.74%+11.54%+17.53% 6.49B
-1.29%-0.24%-2.84%+17.27% 5.32B
+1.27%-3.62%-11.95%-16.19% 3.53B
Average +2.01%+0.52%-2.70%+45.69% 22.6B
Weighted average by Cap. +0.68%+1.93%+10.09%+107.17%

Financials

2026 *2027 *
Net sales 13.54B 9.55B 8.25B 7.6B 7.11B 13.33B 908B 89.75B 34.99B 442B 35.84B 35.08B 1,530B 14.15B 9.98B 8.62B 7.94B 7.43B 13.93B 948B 93.77B 36.56B 462B 37.45B 36.65B 1,598B
Net income 238M 168M 145M 133M 125M 234M 15.93B 1.57B 614M 7.75B 629M 615M 26.84B 244M 172M 148M 137M 128M 240M 16.33B 1.61B 629M 7.95B 645M 631M 27.51B
Net Debt 1.01B 710M 613M 565M 529M 992M 67.52B 6.68B 2.6B 32.86B 2.67B 2.61B 114B 969M 684M 590M 544M 509M 954M 64.98B 6.42B 2.5B 31.63B 2.57B 2.51B 110B
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,800
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.71AUD
Average target price
25.84AUD
Spread / Average Target
+45.94%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!